Table 1 Clinical characteristics and outcomes of patients underwent laparoscopic sleeve gastrectomy surgery suspected of S. marcescens infection
| Â | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 |
|---|---|---|---|---|---|
Age (years) | 32 | 36 | 25 | 25 | 43 |
Gender | Female | Female | Male | Female | Female |
Body mass index, kg/m2 | 37.65 | 48.44 | 58.46 | 44.98 | 50.9 |
Type of specimen | Non | Blood | Blood | Blood | Blood |
Microbial culture results | - | S. marcescens | S. marcescens | S. marcescens | S. marcescens |
Surgical antibiotic prophylaxis | Cefazolin +Metronidazole | Cefazolin +Metronidazole | Cefazolin +Metronidazole | Cefazolin +Metronidazole | Cefazolin +Metronidazole |
Symptoms of re-hospitalization | Fever (38 °C) and respiratory distress | Fever (38.5 °C) and chills | Fever (39.5 °C) | Fever (39 °C) and chills | Fever (38.5 °C) |
Antibiotics therapy during hospitalization | Meropenem (7 days) Vancomycin (7 pays) Ceftriaxone (1Â day) Clindamycin (2 days) Levofloxacin (1Â day) Linezolid (1Â day) | Metronidazole (3 days) Ceftizoxime (2 days) | Ceftizoxime (5 days) Clindamycin (5 days) | Metronidazole (2 days) Ceftizoxime (2 days) | Amikacin (3 days) Metronidazole (3 days) Ceftizoxime (4 days) |
Systolic blood pressure | 125 | 140 | 135 | 130 | 130 |
Diastolic blood pressure | 71 | 90 | 85 | 70 | 90 |
O2sat at admission | 83 | 95 | 95 | 95 | 84 |
Respiratory rate | 30 | 18 | 19 | 20 | 18 |
Heart rate (pulse) | 110 | 110 | 120 | 110 | 127 |
WBC | 19,100 | 10,600 | 18,000 | 8000 | 5600 |
Neutrophil | 78.8 | 56.6 | 87.2 | 92 | 89.3 |
Lymph | 10.9 | 35 | 8.4 | 5.9 | 8.9 |
ESR | 108 | 90 | 108 | 65 | 61 |
CRP | 130 | 168 | 130 | 187 | 145 |
Length of stay in the ICU (days) | 2 | - | 2 | - | 1 |
Length of stay in the hospital (days) (Primary/readmission) | 11 days 2 / 9 | 9 days 4 / 5 | 9 days 9 / 0 | 6 days 2 / 4 | 7 days 2 / 5 |
Outcome | Discharge | Discharge | Discharge | Discharge | Discharge |